Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2024 | 01-2024 | 10-2023 | 07-2023 | 04-2023 | |
| Operating Expenses | 850 | 2,660 | 2,902 | 3,526 | 3,305 |
| Operating Income | -850 | -2,660 | -2,902 | -3,526 | -3,305 |
| Interest Expense | 2 | 3 | 4 | 2 | 1 |
| Pre-tax Income | -852 | -2,662 | -2,906 | -3,528 | -3,306 |
| Net Income Continuous | -852 | -2,662 | -2,906 | -3,528 | -3,306 |
| Net Income | $-852 | $-2,662 | $-2,906 | $-3,528 | $-3,306 |
| EPS Basic Total Ops | -0.50 | -3.80 | -4.40 | -6.00 | -5.29 |
| EPS Basic Continuous Ops | -1.13 | -3.77 | -4.43 | -5.37 | -5.15 |
| EPS Diluted Total Ops | -0.50 | -3.80 | -4.40 | -6.00 | -5.29 |
| EPS Diluted Continuous Ops | -1.13 | -3.77 | -4.43 | -5.37 | -5.15 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.80 | 4.40 | -6.00 | -4.50 |
| EBITDA(a) | $-837 | $-2,647 | $-2,889 | $-3,513 | $-3,300 |